Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors

NCT00848523 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped insufficient accrual

Conditions

Recurrent Malignant Gliomas

Interventions

DRUG: Panobinostat

Sponsor

Neurological Surgery, P.C.